08/29/2019
by Robert Conklin, Vice President of Sales, Guidepoint Data With the addition of Medtronic (“MDT”) to our Guidepoint Qsight data-sets, we now have 16 company models available across the MedTech space. This timely data, gathered from over 2,000 medical facilities,…
07/01/2019
by Robert Conklin, Vice President of Sales, Guidepoint Data With the addition of Medtronic (“MDT”) to our Guidepoint Qsight data-sets, we now have 16 company models available across the MedTech space. This timely data, gathered from over 1,500 hospitals, offers…
11/15/2018
by Kenny Dolgin, Healthcare Analyst, Data Insights, Guidepoint Guidepoint’s Data Insights team is excited to announce that we have expanded Guidepoint Qsight’s data product offering to include models for Stryker (“SYK”) and Boston Scientific (“BSX”). Prior to Stryker’s Q3…
09/27/2018
When the right response from a research participant can make the difference for your end client, the ability to gather accurate insights from trusted respondents is critical for any companies’ decision-making process. Here’s how Guidepoint helps our clients ascertain the…
09/27/2018
One of the biggest challenges in an information-based economy is finding the right information when you need it. Whether it’s getting up to speed quickly on a project, or gaining insight on competitive landscapes, here’s how we help consulting firms…
09/18/2018
by Kenny Dolgin, Healthcare Analyst, Data Insights, Guidepoint Wright Medical Group N.V. (NASDAQ: WMGI) is a mid-cap medical device company that competes in the orthopedics market with a focus on the upper extremities, lower extremities and biologics product areas. Key…
07/25/2018
by Kenny Dolgin, Healthcare Analyst, Data Insights, Guidepoint Intersect ENT Inc. (NASDAQ: XENT) is a small-cap medical device company which competes in the ear, nose and throat (ENT) market. Since January 2017, Intersect’s stock price has grown 181% making it…
06/14/2018
by Ken Wahl, VP Business Development, Data Insights, Guidepoint Nevro Corp. (NYSE: NVRO) is a key player in the spinal cord stimulation (SCS) market. Since FDA approval of the Senza system in 2015, Nevro has taken ~15% market share from…
05/16/2018
by Kenny Dolgin, Data Insights, Guidepoint Abiomed, Inc. (NYSE: ABMD) is a leader in the percutaneous heart pump device market, having launched its first Impella device in 2008 and have since released four iterations with varying flow rates. From May…
04/18/2018
by Kenny Dolgin, Data Insights, Guidepoint Edwards Lifesciences Corp. (NYSE: EW) is a leader in the approximately $3 billion transcatheter heart valve (THV) market, having launched their first SAPIEN valve in the U.S. in 2011 and now having released their…